https://www.prnewswire.com/news-releases/immunofoco-presents-preclinical-data-for-imv102-an-in-vivo-car-t-candidate-demonstrating-durable-tumor-control-at-the-aacr-2026-302747082.html
Immunofoco Presents Preclinical Data for IMV102, an In Vivo CAR-T Candidate, Demonstrating Durable...
/PRNewswire/ -- Immunofoco today announced the presentation of new preclinical data for its in vivo BCMA-targeting CAR-T candidate, IMV102, at the AACR...